... cm 2 in the MA, 0.09 ± 0.03 cm 2 in the MB, 0.0.7 ± 0. 02 cm 2 in the UA, 0.18 ± 0.04 cm 2 in the TA, and 0.05 ± 0.01 cm 2 in the SA. The CSAs in the controls were 0.08 ± 0. 02 cm 2 in the ... next to the hand in the somatotopic map and by anaesthetizing the forearm, the cortical hand area can rapidly expand over the forearm area resulted in improved sensory function ofthe hand in ... et al, and Huang & Liu informatively review aspects ofthe use of medicinal plants, nutritional therapy and the pharmacogenetics of anti-diabetic drugs in the treatment oftype2 diabetes. ...
... pregnancy. Jama 20 05, 29 4 :27 51 -27 57.49. Kim C, Newton KM, Knopp RH: Gestational diabetesandthe incidence of type2 diabetes: a systematic review. Diabetes Care 20 02, 25 :18 62- 1868.50. Ben-Haroush ... Metab 20 08, 93 :24 47 -24 53.46. International Expert Committee report on the role ofthe A1C assay in the diagnosis of diabetes. Diabetes Care 20 09, 32: 1 327 -1334.47. Proceedings ofthe 4th International ... KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre -diabetes in the U.S. population in 1988-1994 and 20 05 -20 06. Diabetes Care 20 09, 32: 287 -29 4.doi: 10.1186/cc9101Cite this article...
... SignificanceFlexibility 120 ± 25 115 ± 22 n.s. Strength 126 ± 23 120 ± 22 n.s. Vibration 133 ± 57 122 ± 35 n.s. HbA1C At baseline the HbA1c amounted to 6,7 % ± 0 ,26 (FT), 6,8 % ± 0,17 (ST), and 7,3 % ± ... Baum, Prof. Dr., Trainingsinstitut, Wilhelm-Schlombs-Allee 1, 50858 Köln, Germany. Telephone (0049) 22 1 28 558550 Fax 28 5585 525 E-mail baum@professor-baum.de Received: 20 07. 02. 28; Accepted: 20 07.05 .29 ; ... measured at rest and within the last 30 s of each load. In addition, body weight and blood pressure were measured before each training session. The mean values ofthe initial and last five sessions...
... Phenotype in Mothers and in Their Offspring 22 7 Valeria Hirschler Chapter 13 The Bidirectional Relationship Between Psychiatry and Type2Diabetes Mellitus 23 7 Menan Rabie Chapter 14 Type2Diabetes ... the age of 60 the number of D2 patients is essentially higher. The ratio between the number of D2 patients andthe number of active people (people between 20 and 60) in 20 03 equals 0. 120 8, while ... Number of people in Slovenia from 20 03 to 20 52 0 10 20 30 40 50 60 70 80 90 10001000 20 003000400050006000age [yeas]number 20 03 20 52 Fig. 16. Number of D2 patients from 20 03 to 20 52 ...
... Adipocyte Theory: The Forces of Clustering at Glance 23 O´Dea K (19 92) . Obesity anddiabetes in the land of milk and honey. Diabetes Metabolism Review Vol.8, No.4 (December 19 92) , pp. 373-88. ... Development ofType2Diabetes 16effects (Tang et al., 20 01), acting as co-adjuvants in the reduction ofthe incident ofdiabetes (Doggrell, 20 02) , increasing vascular function and lowering ... Statements and opinions expressed in the chapters are these ofthe individual contributors and not necessarily those ofthe editors or publisher. No responsibility is accepted for the accuracy of information...
... have been used as standard therapeutic agents forthe treatment of dia-betes [7]. The mechanism of action ofthe anti-diabetic agents used forthe treatment oftype2 diabetes, in-clude increasing ... toxicity in beta-cells: type2 diabetes, good radicals gone bad, andthe glu-tathione connection. Diabetes. 20 03; 52: 581-587. 7. Bell DS. Type2diabetes mellitus: what is the optimal treatment ... Med. 20 04; 116: 23 S -29 S. 8. Wagman AS, and Nuss JM. Current therapies and emerging targets forthe treatment of diabetes. Current Pharmaceutical Design. 20 01; 7: 417-450. 9. Wood IS, and Trayhurn...
... and Therapy 20 09, 6:9 http://www.aidsrestherapy.com/content/6/1/9Page 2of 6(page number not for citation purposes)BackgroundWhilst the first cases of AIDS were identified in the USA[1 ,2] , ... infected had risen to 20 ,745by 1987 [8]. The rapid spread of HIV over the early pre-treatment years is testament to the aggressive nature of the diseaseandthe importance of using effective drugs ... [ARCA], Anders Sönnerborg [Karolinska], Rolf Kaiser [Arevir] for their data and Yardena Peres [IBM, Israel] forthe integration of these data; all other part-ners within the EuResist project for...
... 1Low-intermediate 6Intermediate-high 2 Bulky disease 1B-symptoms 0Prior therapy including rituximabNo 2 Yes 7Number of previous regimens 12 25> ;2 2Table 2 Clinical characteristicsPatients ... dexamethasone and rituximab,remaining in CR for 48 months. He died at 73 years of age for sepsis during support therapy for t-MDS. Ot hertwo patients have died: one for acute renal failure and one for ... consolidation forthe treatment of relapsed grades 1 and2 follicular lymphoma:a report of 9 casesFrancesco Pisani1*, Carlo Ludovico Maini 2 , Rosa Sciuto 2 , Laura Dessanti1, Mariella D’Andrea1,...